-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
First developed by by byk Gulden of Germany, it was first introduced in Germany in 1994 under the name Pantoloc and was approved by the FDA for listing in the United States in 2001.
pythola is a proton pump inhibitor (PPI), clinically suitable for heterostomy, stomach ulcers, moderate and severe refractic esophagitis, dithral ulcers, stomach ulcers, acute gastric mucosal lesions, compound stomach ulcers, etc. caused by acute upper gastrointestinal bleeding.
china Pharmaceutical Information Center PDB database, sales in 2019 reached 1.134 billion yuan, the market size is large.
Osaikang's injection of sodium vitolazole has been the first to pass a consistency evaluation on October 20, the domestic is applying / as if to apply for the drug consistency evaluation of 17 manufacturers, including China Resources Shuanghe, Puli Pharmaceuticals and Nanjing Zhengda Tianqing.
。